GSK (GSK) News Today $37.54 +1.32 (+3.64%) As of 03:53 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GSK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period FTSE 100 Live 14 May: GSK unveils $2bn acquisition, Imperial Brands posts resultsMay 15 at 6:49 AM | msn.comIs GSK plc (GSK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?May 15 at 4:45 AM | finance.yahoo.comBank of America Corp DE Sells 278,431 Shares of GSK plc (NYSE:GSK)Bank of America Corp DE lessened its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 12.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,982,263 shares of the pharmaceutical company's stock after seMay 15 at 4:02 AM | marketbeat.comGSK plc (NYSE:GSK) Receives $40.58 Average Target Price from BrokeragesMay 15 at 2:27 AM | americanbankingnews.comLetko Brosseau & Associates Inc. Raises Position in GSK plc (NYSE:GSK)Letko Brosseau & Associates Inc. grew its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 32.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,623,203 shares of the pharmaceutical company's stocMay 14 at 7:14 AM | marketbeat.comUnitedHealth approves $1M annual base salary for new CEOMay 14 at 7:07 AM | seekingalpha.comLMR Partners LLP Has $13 Million Stake in GSK plc (NYSE:GSK)LMR Partners LLP reduced its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 81.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 384,302 shares of the pharmaceutical company's stock after selling 1,634,890 shares duringMay 14 at 7:02 AM | marketbeat.comCetera Investment Advisers Sells 9,739 Shares of GSK plc (NYSE:GSK)Cetera Investment Advisers trimmed its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 3.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 262,599 shares of the pharmaceutical company's sMay 14 at 4:39 AM | marketbeat.comGSK plc (NYSE:GSK) Shares Sold by Captrust Financial AdvisorsCaptrust Financial Advisors lowered its position in GSK plc (NYSE:GSK - Free Report) by 93.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 80,522 shares of the pharmaceutical company's stock after selling 1,138,322 sMay 14 at 4:29 AM | marketbeat.comGSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 BillionMay 14 at 2:42 AM | wsj.comGSK to buy efimosfermin for up to $2 billionMay 14 at 2:24 AM | reuters.comGSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)May 14 at 2:14 AM | businesswire.comiTeos, GSK End Collaboration On Experimental Cancer Therapy Development: But Retail’s Extremely BullishMay 13 at 4:05 PM | msn.comiTeos, GSK to shelve TIGIT drug after study setbackMay 13 at 4:05 PM | yahoo.comGSK, iTeos End Development of Experimental Lung Cancer DrugMay 13 at 4:05 PM | bloomberg.comGSK slips Tuesday, underperforms marketMay 13 at 4:05 PM | marketwatch.comGSK, partner iTeos scrap development of lung cancer therapyMay 13 at 4:05 PM | msn.comGSK Executives Acquire Shares Under Reward PlanMay 13 at 10:41 AM | tipranks.comITeos, GSK discontinue lung cancer therapy developmentMay 13 at 8:21 AM | reuters.comKahn Brothers Group Inc. Buys Shares of 884,708 GSK plc (NYSE:GSK)Kahn Brothers Group Inc. bought a new stake in GSK plc (NYSE:GSK - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 884,708 shares of the pharmaceutical company's stock, valuedMay 13 at 7:46 AM | marketbeat.comIndia's GlaxoSmithKline Pharma reports profit rise on strong demandMay 13 at 7:45 AM | reuters.comEthic Inc. Buys 8,586 Shares of GSK plc (NYSE:GSK)Ethic Inc. lifted its stake in GSK plc (NYSE:GSK - Free Report) by 8.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 106,904 shares of the pharmaceutical company's stock after acquiring an additional 8,586 shares dMay 13 at 6:32 AM | marketbeat.comBNP Paribas Financial Markets Invests $12.42 Million in GSK plc (NYSE:GSK)BNP Paribas Financial Markets bought a new stake in GSK plc (NYSE:GSK - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 367,315 shares of the pharmaceutical company's stoMay 13 at 5:05 AM | marketbeat.comGSK plc (NYSE:GSK) Receives Average Rating of "Hold" from AnalystsShares of GSK plc (NYSE:GSK - Get Free Report) have been given an average rating of "Hold" by the twelve analysts that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and thrMay 13 at 2:25 AM | marketbeat.comAstraZeneca and GSK in the firing line as Trump targets big pharma: ALEX BRUMMERMay 13 at 1:47 AM | msn.comGSK and Astrazeneca shares slump as Trump vows drug price cutMay 12 at 8:47 PM | msn.comGSK partners with Lifetime for 'Pretty Hurts' movie to promote meningitis awarenessMay 12 at 8:47 PM | bizjournals.comFORA Capital LLC Acquires New Shares in GSK plc (NYSE:GSK)FORA Capital LLC bought a new position in shares of GSK plc (NYSE:GSK - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 32,531 shares of the pharmaceutical company's stock, valued at apprMay 12 at 5:43 AM | marketbeat.comClark Capital Management Group Inc. Has $22.24 Million Holdings in GSK plc (NYSE:GSK)Clark Capital Management Group Inc. cut its stake in shares of GSK plc (NYSE:GSK - Free Report) by 48.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 657,451 shares of the pharmaceutical company's stock after selling 623,938 sharesMay 11, 2025 | marketbeat.comCrestline Management LP Takes Position in GSK plc (NYSE:GSK)Crestline Management LP purchased a new stake in shares of GSK plc (NYSE:GSK - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 30,970 shares of the pharmaceutical company's stock, valuedMay 11, 2025 | marketbeat.comHsbc Holdings PLC Sells 2,546,222 Shares of GSK plc (NYSE:GSK)Hsbc Holdings PLC lessened its holdings in GSK plc (NYSE:GSK - Free Report) by 99.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,182 shares of the pharmaceutical company's stock after selling 2,546,222 shares during the period. Hsbc HoldingsMay 11, 2025 | marketbeat.comDon't Race Out To Buy GSK plc (LON:GSK) Just Because It's Going Ex-DividendMay 10, 2025 | finance.yahoo.comGSK Enhances Shareholder Value with Recent BuybackMay 9, 2025 | tipranks.comBayesian Capital Management LP Makes New Investment in GSK plc (NYSE:GSK)Bayesian Capital Management LP acquired a new stake in shares of GSK plc (NYSE:GSK - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,037 shares of the pharmaceutical coMay 9, 2025 | marketbeat.comGSK hails phase 3 results on linerixibat in treating relentless itchMay 8, 2025 | lse.co.ukGSK plc (NYSE:GSK) Shares Bought by Bridgefront Capital LLCBridgefront Capital LLC grew its stake in GSK plc (NYSE:GSK - Free Report) by 73.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,665 shares of the pharmaceutical company's stock after purchasing an aMay 8, 2025 | marketbeat.comNorthern Trust Corp Has $69.68 Million Stock Holdings in GSK plc (NYSE:GSK)Northern Trust Corp grew its stake in GSK plc (NYSE:GSK - Free Report) by 16.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,060,255 shares of the pharmaceutical company's stock after purchasing an addiMay 8, 2025 | marketbeat.comGSK plc (NYSE:GSK) Stock Holdings Increased by Beverly Hills Private Wealth LLCBeverly Hills Private Wealth LLC raised its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 94.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 29,397 shares of the pharmaceutical company's stock after buying an additioMay 7, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Sells 16,258 Shares of GSK plc (NYSE:GSK)Mercer Global Advisors Inc. ADV cut its stake in shares of GSK plc (NYSE:GSK - Free Report) by 10.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 140,087 shares of the pharmaceutical company's stockMay 7, 2025 | marketbeat.comDown 20% over the year, is GSK’s share price a stunning bargain after its Q1 results?May 7, 2025 | msn.comGSK plc (NYSE:GSK) Shares Sold by Invesco Ltd.Invesco Ltd. reduced its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 67.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,606 shares of the pharmaceutical company's stock after sellingMay 6, 2025 | marketbeat.com5 Reasons GSK Looks GoodMay 5, 2025 | seekingalpha.comAristotle Capital Management LLC Sells 187,055 Shares of GSK plc (NYSE:GSK)Aristotle Capital Management LLC trimmed its stake in GSK plc (NYSE:GSK - Free Report) by 10.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,601,320 shares of the pharmaceutical company's stocMay 5, 2025 | marketbeat.comBarclays PLC Buys 22,689 Shares of GSK plc (NYSE:GSK)Barclays PLC grew its stake in GSK plc (NYSE:GSK - Free Report) by 84.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 49,628 shares of the pharmaceutical company's stock after acquiring an additional 2May 5, 2025 | marketbeat.comHsbc Global Res Upgrades GSK (NYSE:GSK) to Strong SellHsbc Global Res raised GSK to a "strong sell" rating in a report on Monday.May 3, 2025 | marketbeat.comGSK plc (NYSE:GSK) Position Increased by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company lifted its position in GSK plc (NYSE:GSK - Free Report) by 29.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,318,799 shares of the pharmMay 3, 2025 | marketbeat.comGSK (NYSE:GSK) Releases FY 2025 Earnings GuidanceGSK (NYSE:GSK) updated its FY 2025 earnings guidance. The company provided EPS guidance of 4.250-4.590 for the period, compared to the consensus estimate of 4.360. The company also issued revenue guidance of $40.7 billionillion-$42.7 billionillion, compared to the consensus estimate of $32.6 billionillion.May 2, 2025 | marketbeat.comGSK plc (NYSE:GSK) Shares Bought by Dimensional Fund Advisors LPDimensional Fund Advisors LP lifted its position in shares of GSK plc (NYSE:GSK - Free Report) by 0.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,598,570 shares of the pharmaceutical comMay 2, 2025 | marketbeat.comGSK PLC (GSK) Q1 2025 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ...May 1, 2025 | finance.yahoo.comQ1 2025 GSK plc Earnings Call TranscriptMay 1, 2025 | gurufocus.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.810.79▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼3418▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Today Novartis News Today AstraZeneca News Today Sanofi News Today Takeda Pharmaceutical News Today argenx News Today BioNTech News Today Beigene News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GSK Stock Free GSK Stock Alerts